The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein A1 and for modulating anti-HDL antibodies.
Marinho AT, Batuca JR, Miranda JP, Caixas U, Dias CG, Branco T, Soto K, Pinheiro P, Bourbon M, Marques MM, Antunes AM, Monteiro EC, Pereira SA.
Marinho AT, et al. Among authors: marques mm.
Pharmacol Res. 2021 Mar;165:105446. doi: 10.1016/j.phrs.2021.105446. Epub 2021 Jan 27.
Pharmacol Res. 2021.
PMID: 33515705